Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
46
pubmed:dateCreated
2008-11-21
pubmed:abstractText
Refsum disease is caused by a deficiency of phytanoyl-CoA hydroxylase (PHYH), the first enzyme of the peroxisomal alpha-oxidation system, resulting in the accumulation of the branched-chain fatty acid phytanic acid. The main clinical symptoms are polyneuropathy, cerebellar ataxia, and retinitis pigmentosa. To study the pathogenesis of Refsum disease, we generated and characterized a Phyh knockout mouse. We studied the pathological effects of phytanic acid accumulation in Phyh(-/-) mice fed a diet supplemented with phytol, the precursor of phytanic acid. Phytanic acid accumulation caused a reduction in body weight, hepatic steatosis, and testicular atrophy with loss of spermatogonia. Phenotype assessment using the SHIRPA protocol and subsequent automated gait analysis using the CatWalk system revealed unsteady gait with strongly reduced paw print area for both fore- and hindpaws and reduced base of support for the hindpaws. Histochemical analyses in the CNS showed astrocytosis and up-regulation of calcium-binding proteins. In addition, a loss of Purkinje cells in the cerebellum was observed. No demyelination was present in the CNS. Motor nerve conduction velocity measurements revealed a peripheral neuropathy. Our results show that, in the mouse, high phytanic acid levels cause a peripheral neuropathy and ataxia with loss of Purkinje cells. These findings provide important insights in the pathophysiology of Refsum disease.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-10442551, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-11060349, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-11229711, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-11923221, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-11948235, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-12700346, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-14974078, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-15649701, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-15654129, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-16386870, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-16499884, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-16616447, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-17604218, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-2581787, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-4159604, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-6157716, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-6186770, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-7538630, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-85164, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-9053557, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-9053558, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-9321461, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-9341179, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-9488698, http://linkedlifedata.com/resource/pubmed/commentcorrection/19004801-9674927
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
18
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
17712-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:19004801-Animals, pubmed-meshheading:19004801-Ataxia, pubmed-meshheading:19004801-Automation, pubmed-meshheading:19004801-Behavior, Animal, pubmed-meshheading:19004801-Central Nervous System, pubmed-meshheading:19004801-Dietary Supplements, pubmed-meshheading:19004801-Disease Models, Animal, pubmed-meshheading:19004801-Gait, pubmed-meshheading:19004801-Gene Targeting, pubmed-meshheading:19004801-Genetic Vectors, pubmed-meshheading:19004801-Lipidoses, pubmed-meshheading:19004801-Male, pubmed-meshheading:19004801-Mice, pubmed-meshheading:19004801-Mixed Function Oxygenases, pubmed-meshheading:19004801-Peripheral Nervous System Diseases, pubmed-meshheading:19004801-Phenotype, pubmed-meshheading:19004801-Phytanic Acid, pubmed-meshheading:19004801-Phytol, pubmed-meshheading:19004801-Purkinje Cells, pubmed-meshheading:19004801-Refsum Disease, pubmed-meshheading:19004801-Spermatogonia
pubmed:year
2008
pubmed:articleTitle
Ataxia with loss of Purkinje cells in a mouse model for Refsum disease.
pubmed:affiliation
Academic Medical Center, Department of Clinical Chemistry (Laboratory of Genetic Metabolic Diseases), Emma's Children Hospital, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. s.ferdinandusse@amc.uva.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't